25 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.
Pfizer
Organic anion transporter 3 interacts selectively with lipophilicß-lactam antibiotics.
Wilkes University
Evaluation and prediction of potential drug-drug interactions of linagliptin using in vitro cell culture methods.
Nippon Boehringer Ingelheim
Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
Kyorin University
Interaction of human organic anion transporters with various cephalosporin antibiotics.
Kyorin University
Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters.
Kyorin University
Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions.
University of Tokyo
Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier.
The University of Tokyo
Interactions of human organic anion as well as cation transporters with indoxyl sulfate.
Nagoya University School of Medicine
Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux.
Georg-August-Universit£T
Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A).
Kyoto University Hospital
Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine.
Kyorin University
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
Novartis Pharma
Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic Pain.
Bristol-Myers Squibb
Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
Hemoshear Therapeutics
Discovery of Pamiparib (BGB-290), a Potent and Selective Poly (ADP-ribose) Polymerase (PARP) Inhibitor in Clinical Development.
TBA
Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase Inhibitors through Liver Targeting.
Pfizer
Pharmacological urate-lowering approaches in chronic kidney disease.
West China Hospital of Sichuan University
Dihydrophenanthrenes from Juncus effusus as Inhibitors of OAT1 and OAT3.
Tianjin University
Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.
Kyorin University School of Medicine
Characterization of ochratoxin A transport by human organic anion transporters.
Kyorin University
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.
University of Tokyo
Characterization of uremic toxin transport by organic anion transporters in the kidney.
University of Tokyo
SERIES OF PIPERIDINE-SUBSTITUTED BENZOIC ACID COMPOUNDS, AND USE THEREOF
Medshine Discovery